Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Abbott and Roche both see strong demand for PCR testing into 2022. Novacyt announce September as the best trading month in the companys history. I would suspect a bullish update is due. They have reiterated the £100m revenue guidance for this year but could well exceed that depending how well Q4 does. We rather under promise over deliver. fundamentals always come through in the end. If the market is not reacting to this then it creates a buying opportunity.
Hiber plex could be something similar to this https://hibergene.com/products/respiratory/hg-covid-19/
Left it a bit late but been rewlly busy this past week with work. Anyway, just logged onto my Barclays Stockbroker and noticed the date for voting has passed as it was 11 October. However, Novacyt did say we had until midnight tonight. Anyone experienced this? How to overcome it?
Something picked up on a while back now was the company expanding into cancer diagnostics and whether the change in CEO was a move in that direction. All seems to make sense now withh DA having 10 years experience at Amgen. Interesting times ahead.
Links to ‘Emergency PCR scale up contracts’ posted on twitter thanks to Blackbird investing. Very interesting awards in these past few days. Are they expecting a surge and how does this fit in with Nova and the dispute. Very interesting…
Total disconnect between fundamental value and market value and also constant driving down of the SP are common signs of a hostile TO. Btw a hostile approach is not good for shareholders we will most likely see a very low ball offer still leaving us all with a loss
Any offer will come in the New year when the 12 month high will be lower. Thats if we are still at these ridiculous levels. By then i expect a lot more progress on many fronts. I am particularly keen on the US market over the next few months. We have a team out there selling products they are particularly keen on with very little competiton e.g winterplex.
Expecting a bumper increase considering how well some of our partners did, peak summer months aswel. Under promise over deliver. Also, CO-prep and winterplex should land us some nice revenue in Q4. I remain optimistic about our future. DHSC aside, the compny will have sufficient cash at year end acquire and expand into non covid markets. Be greedy when everyone else is fearful!
Goodluck Brook. Tough to watch your investment slide like this. However, as easy as it is to get distracted by SP performance the key is to look at the basic fundamentals of the company and future prospects. IMO at this price i wish i could load more.